Furthermore, DTX3L expression is higher in triple-negative breast cancer cells than in estrogen receptor (ER) positive and human epidermal growth factor receptor 2 (HER2) positive breast cancers, and is a part of the negative feedback loop controlling all-trans retinoic acid (ATRA)-dependent inhibition of breast cancer cell growth (Bolis et al., 2020). This evidence concerns the gene DTX3L and breast carcinoma.